Mental state: 2f. Activation symptoms ‐ average endpoint score (BPRS activation sub‐score, high = poor) | ||||
---|---|---|---|---|
Study | Intervention | Mean | SD | N |
short term (up to 12 weeks) | ||||
Conley 2005 | Qutiapine | 7.33 | 2.77 | 12 |
Conley 2005 | Risperidone | 7.00 | 3.06 | 13 |
Mental state: 2f. Activation symptoms ‐ average endpoint score (BPRS activation sub‐score, high = poor) | ||||
---|---|---|---|---|
Study | Intervention | Mean | SD | N |
short term (up to 12 weeks) | ||||
Conley 2005 | Qutiapine | 7.33 | 2.77 | 12 |
Conley 2005 | Risperidone | 7.00 | 3.06 | 13 |